Immunic, Inc. Share Price

Immunic, Inc. Share Price

NASDAQ: IMUX | Small Cap
$7.88
-$0.06 (-0.69%) Last updated on 29 Oct, 2026 | 22:40 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immunic, Inc. Stock Performance

Open
$8.09
Prev. Close
$7.94
Circuit Range
N/A
Day Range
$7.86 - $8.12
Year Range
$0.51 - $17.34
Volume
7,862
Average Traded
$7.97

Immunic, Inc. Share Price Today

As of 29 October 2026, Immunic, Inc.'s share price is $7.88. The stock opened at $8.09, compared to its previous close of $7.94. During today's trading session, Immunic, Inc.'s share price traded between $7.86 and $8.12, with an average price of $7.99. Over the past 52 weeks, the stock has recorded a high of $17.34 and a low of $0.51. In terms of performance, Immunic, Inc.'s share price has declined by 17.86% over the last six months and is up 916.11% on a year-on-year basis.

Immunic, Inc. Share Price Chart

Line chart of the Immunic, Inc. price trend over the selected period. The price fell overall, ranging from 7.86 to 8.12, ending at 7.88.
$7.86$8.12
L
Show Current Price
H

Immunic, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.23B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-8.18
Revenue (TTM)
$0.00
Return On Equity (TTM)
-87.45%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-33.31%

Immunic, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$25.58-$19.30-$32.59-$34.10
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A24.55%-68.86%-4.63%

Immunic, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$120.41-$93.61-$100.51-$97.17
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A22.26%-7.37%3.32%

About Immunic, Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Immunic, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$9.22
$7.89
-15.97%
Sep 2026
$16.02
$9.39
-42.39%
Aug 2026
$13.91
$16.30
+16.51%
Jul 2026
$15.12
$13.99
-9.27%
Jun 2026
$15.21
$15.42
+2.94%
May 2026
$9.65
$14.98
+56.04%
Apr 2026
$1.14
$9.60
+768.78%
Mar 2026
$0.99
$1.10
+9.41%
Feb 2026
$0.62
$1.01
+63.17%
Jan 2026
$0.55
$0.62
+16.14%
Dec 2025
$0.71
$0.53
-25.14%
Nov 2025
$0.77
$0.71
-8.25%

IMUX Share Price FAQs